Drug Shortage Report for ERYTHRO-BASE
Report ID | 134555 |
Drug Identification Number | 00682020 |
Brand name | ERYTHRO-BASE |
Common or Proper name | Erythro-Base |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-02-22 |
Estimated end date | 2022-09-01 |
Actual end date | 2022-04-01 |
Shortage status | Resolved |
Updated date | 2022-04-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-02-22 | English | Compare |
v2 | 2021-02-22 | French | Compare |
v3 | 2021-02-23 | English | Compare |
v4 | 2021-03-25 | English | Compare |
v5 | 2021-03-25 | French | Compare |
v6 | 2021-05-19 | English | Compare |
v7 | 2021-05-19 | French | Compare |
v8 | 2021-05-27 | English | Compare |
v9 | 2021-05-27 | French | Compare |
v10 | 2021-12-09 | English | Compare |
v11 | 2021-12-09 | French | Compare |
v12 | 2021-12-23 | English | Compare |
v13 | 2021-12-23 | French | Compare |
v14 | 2022-01-07 | English | Compare |
v15 | 2022-01-07 | French | Compare |
v16 | 2022-01-20 | English | Compare |
v17 | 2022-01-20 | French | Compare |
v18 | 2022-01-26 | English | Compare |
v19 | 2022-01-26 | French | Compare |
v20 | 2022-02-09 | English | Compare |